BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fuster J, Charco R, Llovet JM, Bruix J, García-Valdecasas JC. Liver transplantation in hepatocellular carcinoma. Transpl Int. 2005;18:278-282. [PMID: 15730486 DOI: 10.1111/j.1432-2277.2004.00046.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Parrilla P, Ramírez P. [New scenarios in liver transplantation]. Cir Esp 2005;78:209-13. [PMID: 16420828 DOI: 10.1016/s0009-739x(05)70921-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Moya Herráiz A, Torres-Quevedo R, Mir Pallardó J. [Liver transplant in patients with hepatocellular carcinoma]. Cir Esp 2008;84:117-24. [PMID: 18783669 DOI: 10.1016/s0009-739x(08)72152-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
3 De Giorgio M, Vezzoli S, Cohen E, Armellini E, Lucà MG, Verga G, Pinelli D, Nani R, Valsecchi MG, Antolini L. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transpl. 2010;16:503-512. [PMID: 20373461 DOI: 10.1002/lt.22039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
4 Sapisochin G, Bilbao I, Balsells J, Dopazo C, Caralt M, Lázaro JL, Castells L, Allende H, Charco R. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg 2010;34:2146-54. [PMID: 20411387 DOI: 10.1007/s00268-010-0583-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
5 Zhang Z, Liu J, Liu Y, Li Z, Gao W, He Z. Generation, characterization and potential therapeutic applications of mature and functional hepatocytes from stem cells. J Cell Physiol 2013;228:298-305. [DOI: 10.1002/jcp.24150] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
6 Perrillo RP, Eason JD. The use of HBsAg-positive organ donors: Far more than meets the eye? Liver Transpl 2005;11:875-7. [DOI: 10.1002/lt.20449] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
7 Varona MA, Del Pino JM, Barrera M, Arranz J, Hernández BM, Perez HF, Padilla J, Fuentes JS, Aguirre A, Mendez S. Hepatocellular carcinoma and liver transplantation: a 12-year experience. Transplant Proc. 2009;41:1005-1008. [PMID: 19376411 DOI: 10.1016/j.transproceed.2009.02.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
8 Abdelfattah MR, Elsiesy H, Al-Manea H, Broering DC. Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study. Eur J Gastroenterol Hepatol 2018;30:398-403. [PMID: 29280920 DOI: 10.1097/MEG.0000000000001044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, Mariani L. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011;17 Suppl 2:S44-S57. [PMID: 21695773 DOI: 10.1002/lt.22365] [Cited by in Crossref: 320] [Cited by in F6Publishing: 296] [Article Influence: 32.0] [Reference Citation Analysis]
10 Kishi Y, Sugawara Y, Tamura S, Kaneko J, Kokudo N, Makuuchi M. Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantation. Transplant Int 2006;19:720-5. [DOI: 10.1111/j.1432-2277.2006.00338.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
11 Woo HY, Jang JW, Choi JY, You CR, Jeong SW, Bae SH, Yoon SK, Lee YS, Kim DG. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria. Liver Int. 2008;28:1120-1128. [PMID: 18492023 DOI: 10.1111/j.1478-3231.2008.01785.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
12 Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients. Liver Transpl. 2007;13:687-692. [PMID: 17457911 DOI: 10.1002/lt.21138] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
13 Di Sandro S, Sposito C, Lauterio A, Najjar M, Droz Dit Busset M, Buscemi V, Flores Reyes M, De Carlis R, Mazzaferro V, De Carlis L. Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients. J Am Coll Surg 2018;226:1147-59. [PMID: 29574178 DOI: 10.1016/j.jamcollsurg.2018.03.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
14 Zhang Z, Gong Y, Guo Y, Hai Y, Yang H, Yang S, Liu Y, Ma M, Liu L, Li Z, Gao WQ, He Z. Direct transdifferentiation of spermatogonial stem cells to morphological, phenotypic and functional hepatocyte-like cells via the ERK1/2 and Smad2/3 signaling pathways and the inactivation of cyclin A, cyclin B and cyclin E. Cell Commun Signal 2013;11:67. [PMID: 24047406 DOI: 10.1186/1478-811X-11-67] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
15 Baccarani U, Adani GL, Avellini C, Lorenzin D, Currò G, Beltrami A, Pasqualucci A, Bresadola V, Risaliti A, Viale PL, Beltrami CA, Bresadola F. Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center. Transplant Proc 2006;38:1111-3. [PMID: 16757280 DOI: 10.1016/j.transproceed.2006.02.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
16 Unek T, Karademir S, Arslan NC, Egeli T, Atasoy G, Sagol O, Obuz F, Akarsu M, Astarcioglu I. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma. World J Gastroenterol 2011; 17(37): 4206-4212 [PMID: 22072852 DOI: 10.3748/wjg.v17.i37.4206] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sapisochin G, Sevilla EF, Echeverri J, Charco R. Management of “very early” hepatocellular carcinoma on cirrhotic patients. World J Hepatol 2014; 6(11): 766-775 [PMID: 25429314 DOI: 10.4254/wjh.v6.i11.766] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
18 Volk ML, Marrero JA, Lok AS, Ubel PA. Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. Transplantation 2006;82:1136-9. [PMID: 17102762 DOI: 10.1097/01.tp.0000245670.75583.3d] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
19 Sapisochin G, Castells L, Dopazo C, Bilbao I, Minguez B, Lázaro JL, Allende H, Balsells J, Caralt M, Charco R. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol. 2013;20:1194-1202. [PMID: 22965574 DOI: 10.1245/s10434-012-2655-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
20 Zhang X, Wu Z, Peng Y, Li D, Jiang Y, Pan F, Li Y, Lai Y, Cui Z, Zhang K. Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. Biomed Res Int 2021;2021:6651397. [PMID: 33954191 DOI: 10.1155/2021/6651397] [Reference Citation Analysis]
21 Ren J, Jia J, Zhang H, Zhang L, Ma B, Jiang H, Di L, Song G, Yu J. Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma. Cancer Sci 2008;99:1420-6. [PMID: 18422751 DOI: 10.1111/j.1349-7006.2008.00820.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]